6505--Hydralazine HCL Injections Award - Hikma Pharmaceuticals

SOL #: 36E79725R0048Justification

Overview

Buyer

Veterans Affairs
Veterans Affairs, Department Of
NAC PHARMACEUTICALS (36E797)
HINES, IL, 60141, United States

Place of Performance

Place of performance not available

NAICS

Pharmaceutical Preparation Manufacturing (325412)

PSC

Drugs And Biologicals (6505)

Set Aside

No set aside specified

Timeline

1
Posted
Nov 21, 2025
2
Last Updated
Nov 21, 2025

Qualification Details

Fit reasons
  • NAICS alignment with historical contract wins in similar service areas.
  • Scope strongly matches core technical capabilities and delivery model.
Risks
  • Past performance thresholds may require one additional teaming partner.
  • Potential clarification needed on staffing minimums before bid/no-bid.
Next steps

Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.

This acquisition did not provide for full and open competition in accordance with FAR 6.302-7. While this acquisition did not provide for full and open competition, the solicitation was posted to SAM.gov and all offerors of U.S.-made product were considered. See the attached justification document for details.

People

Points of Contact

Nicholas McGregorContracting OfficerPRIMARY

Files

Files

Download
Download

Versions

Version 2Viewing
Justification
Posted: Nov 21, 2025
Version 1
Award Notice
Posted: Nov 21, 2025
View
6505--Hydralazine HCL Injections Award - Hikma Pharmaceuticals | GovScope